A cost-effective and efficient reprogramming platform for large-scale production of integration-free human induced

Jeanette Beers1, Kaari L Linask1, Jane A Chen1

  • 1Center for Molecular Medicine, National Heart, Lung and Blood Institute, Bethesda, Maryland.

Scientific Reports
|June 13, 2015
PubMed